CHEMOTHERAPY
Online ISSN : 1884-5894
Print ISSN : 0009-3165
ISSN-L : 0009-3165
CLINICAL EVALUATION OF DL-8280 FOR RESPIRATORY INFECTIOUS DISEASES
TERUO AOYAGIYUICHI KOIZUMI
Author information
JOURNAL FREE ACCESS

1984 Volume 32 Issue Supplement1 Pages 189-192

Details
Abstract
DL-8280 was administered to 7 cass with pneumonia and 2 cases with bronchitis, which was given orally 600 mg per day for 14 days.
The results were as follows:
1) Abnormal shadows in X-ray disappeared in 6 cases and markedly improved in 1 case within 14 days.
2) Both cough and sputum disappeared in 8 cases and markedly-improved in 1 casewithin 14 days.
3) Nobody complained of gastrointestinal disturbance and no abnormal change in hematological and biochemical examination after the treatment was observed.
Therefore all cases were determined as good responses about the therapeutic effect.
It was suggested that DL-8280 was useful drug for respiratory infectious diseases.
Content from these authors
© Japanese Society of Chemotherapy
Previous article Next article
feedback
Top